Tag
Lasa Supergenerics Limited
2 articles
Lasa Supergenerics Q2 FY27 Related Party Disclosures
Lasa Supergenerics discloses related party transactions worth ₹3.33 crore for Q2 and H1 FY27 under SEBI LODR Regulation 23(9).
Transactions include ₹2.43 crore in director remuneration and a ₹2 lakh d
Lasa Supergenerics Q2 FY27 Net Loss ₹183.89 Lakhs
Lasa Supergenerics reported Q2 FY27 net loss of ₹183.89 lakhs with revenue collapsing to ₹1.55 lakhs due to complete operational halt.
Company operations remain suspended since May 2025 fire that caus